Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

2.

Review article: Progress of treatment in ANCA-associated vasculitis.

Jayne D.

Nephrology (Carlton). 2009 Feb;14(1):42-8. doi: 10.1111/j.1440-1797.2009.01101.x. Review.

PMID:
19335843
3.

Update on the European Vasculitis Study Group trials.

Jayne D.

Curr Opin Rheumatol. 2001 Jan;13(1):48-55. Review.

PMID:
11148715
4.

Primary systemic vasculitis.

Day C, Savage C.

Minerva Med. 2001 Oct;92(5):349-63. Review.

PMID:
11675579
5.

Evidence-based management of ANCA vasculitis.

Carruthers D, Sherlock J.

Best Pract Res Clin Rheumatol. 2009 Jun;23(3):367-78. doi: 10.1016/j.berh.2008.12.003. Review.

PMID:
19508944
7.

[Maintainance treatment of anti-neutrophil cytoplasm associated antibodies (ANCA)].

Dábague Guzmán J, Pedroza Granados J, Zúñiga Varga J.

Reumatol Clin. 2011 Dec;7 Suppl 3:S37-40. doi: 10.1016/j.reuma.2011.10.005. Epub 2011 Nov 25. Review. Spanish.

8.

4. Antineutrophil cytoplasmic antibody (ANCA) associated vasculitis: from molecular analysis to bedside.

Yoshida M.

Intern Med. 2002 Jan;41(1):47-9. Review. No abstract available.

9.

Randomized controlled trials in vasculitis associated with anti-neutrophil cytoplasmic antibodies.

Goek ON, Stone JH.

Curr Opin Rheumatol. 2005 May;17(3):257-64. Review.

PMID:
15838233
10.

Current treatment strategies in ANCA-positive renal vasculitis-lessons from European randomized trials.

Tesar V, Ríhová Z, Jancová E, Rysavá R, Merta M; European randomized trials.

Nephrol Dial Transplant. 2003 Jul;18 Suppl 5:v2-4. Review.

PMID:
12817056
11.

Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force.

Mukhtyar C, Flossmann O, Hellmich B, Bacon P, Cid M, Cohen-Tervaert JW, Gross WL, Guillevin L, Jayne D, Mahr A, Merkel PA, Raspe H, Scott D, Witter J, Yazici H, Luqmani RA; European Vasculitis Study Group (EUVAS).

Ann Rheum Dis. 2008 Jul;67(7):1004-10. Epub 2007 Oct 2. Review.

PMID:
17911225
13.

[ANCA-associated vasculitis].

Sinico RA, Sabadini E, Boeri R, Radice A.

G Ital Nefrol. 2002 Mar-Apr;19(2):125-36. Review. Italian.

PMID:
12195410
14.
15.

[New aspects in ANCA-associated vasculitides].

Lamprecht P.

Med Klin (Munich). 2004 Sep 15;99(9):518-22. Review. German.

PMID:
15372181
16.

Vasculitis: clinical approach, pathophysiology and treatment.

Kallenberg CG.

Wien Klin Wochenschr. 2000 Aug 25;112(15-16):656-9. Review.

PMID:
11020951
17.

Management of systemic vasculitis.

Langford CA.

Best Pract Res Clin Rheumatol. 2001 Jun;15(2):281-97. Review.

PMID:
11469822
18.

The antineutrophil cytoplasmic antibody-associated vasculitides.

Seo P, Stone JH.

Am J Med. 2004 Jul 1;117(1):39-50. Review.

PMID:
15210387
19.

What does the future hold for clinical studies in vasculitis?

Hoffman GS.

Clin Exp Immunol. 2011 May;164 Suppl 1:35-8. doi: 10.1111/j.1365-2249.2011.04365.x. Review.

20.

[Wegener's granulomatosis and microscopic polyangiitis].

Pagnoux C.

Rev Prat. 2008 Mar 15;58(5):522-32. Review. French.

PMID:
18524109

Supplemental Content

Support Center